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Guanylyl	   cyclase	   C	   (GC-­‐C)	   is	   a	  member	   of	   particulate	   guanylyl	   cyclases,	   discovered	  
primarily	   as	   the	   target	   of	   a	   family	   of	   heat	   stable	   enterotoxins	   (ST),	   produced	   by	  
enterotoxigenic	  Escherichia	   coli	   (ETEC).	   ST	   is	   acknowledged	  as	   a	  prime	   cause	  of	   traveller’s	  
diarrhea	   and	   the	   leading	   cause	   of	   child	  mortality	   under	   the	   age	   of	   5	   years	   in	   developing	  
nations.	   The	   bacterial	   expression	   of	   ST	   peptides	   represents	  molecular	  mimicry	  where	   the	  
pathogen	  has	  exploited	  a	  gastrointestinal	  tract-­‐signaling	  pathway	  to	  disperse	  and	  propagate.	  
GC-­‐C	   is	   primarily	   expressed	   on	   the	   apical	   or	   the	   brush	   border	   membranes	   of	   intestinal	  
epithelial	  cells.	  GC-­‐C	  agonists	  elaborated	  in	  the	  gastrointestinal	  tract	  are	  a	  family	  of	  guanylin	  
peptides,	  which	  are	  responsible	  for	  maintaining	  fluid-­‐ion	  homeostasis,	  essential	   for	  normal	  
gut	  physiology.	  The	  signal	  of	  ligand	  binding	  to	  the	  extracellular	  domain	  of	  GC-­‐C	  is	  transduced	  
to	  the	  catalytic	  guanylyl	  cyclase	  domain,	  which	  results	   in	  production	  of	   intracellular	  cGMP.	  
The	  elevated	   levels	  of	  cGMP	   influence	  multiple	  downstream	  targets,	  which	   finally	   regulate	  
ion-­‐flux	   through	   the	   transporters	   present	   on	   the	   membrane	   of	   an	   enterocyte.	   The	   ST	  
peptide,	   a	   GC-­‐C	   superagonist,	   produces	   physiologically	   abnormal	   levels	   of	   cGMP	   that	  
manifest	  as	  secretory	  diarrhea.	  
	  
The	  purview	  of	  GC-­‐C	  misregulation	  was	  confined	  to	  the	  notion	  of	  its	  hyperactivation	  
caused	  by	  ETEC	  infection	  and	  the	  ensuing	  diarrhea.	  Recently,	  two	  seminal	  studies	  widened	  
the	   scope	   of	   pathologies	   associated	   with	   GC-­‐C.	   Studies	   described	   point	   mutations	   in	  
GUCY2C,	  which	   were	   associated	   with	   human	   disease.	   One	   study	   identified	   a	   Norwegian	  
family	   whose	   members	   demonstrated	   a	   dominantly	   inherited	   syndrome	   of	   frequent	  
diarrhea	   associated	  with	   hyperactive	   GC-­‐C.	   Following	   this	   study,	   inactivating	  mutations	   in	  
GC-­‐C	  in	  a	  small	  Bedouin	  population	  was	  reported.	  The	  current	  study	  reports	  the	  molecular	  
phenotypes	  associated	  with	  the	  first	  germ	  line	  mutations	  in	  GC-­‐C	  that	  result	  in	  a	  severe	  form	  
of	  congenital	  sodium	  diarrhea.	  
	  
Our	   collaborators	   from	  Austria	   (Thomas	  Muller	  &	  Andreas	   Janecke,	   Department	   of	  
Pediatrics	  Innsbruck	  Medical	  University)	  communicated	  to	  us	  their	  study	  of	  patients	  who	  had	  
clinical	  diagnosis	  of	  congenital	  sodium	  diarrhea,	  with	  proportionally	  high	  fecal	  sodium	  loss,	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Synopsis	  
	   IV	  	  
metabolic	  acidosis	  and	  dehydration.	  Exome	  sequencing	   in	  a	  cohort	  of	  6	  unrelated	  patients	  
revealed	   four	   heterozygous	   missense	   mutations	   in	   GC-­‐C	   (R792S,	   L775P,	   K507E,	   N850D).	  
Novel	  GC-­‐C	  mutations	  were	  de	  novo	  spontaneous	  mutations	  with	  the	  carrier	  being	  the	  only	  
affected	   family	   member	   in	   contrast	   to	   the	   previous	   two	   reports	   with	   familial	   history.	  
Biochemical	   characterization	   revealed	   that	   the	   mutants	   (GC-­‐CR792S,	   GC-­‐CL775P)	   were	  
constitutively	   active	   with	   GC-­‐CR792S,	   GC-­‐CK507E,	   and	   GC-­‐CN850D	   showing	   further	   stimulation	  
upon	  treatment	  with	  ST	  and	  guanylin	  family	  of	  peptides.	  Interestingly,	  there	  was	  no	  change	  
in	   the	   binding	   affinities	   of	   the	   ligands	   for	   the	   mutant	   receptors	   compared	   to	   wild	   type.	  
However,	  a	  significant	  decrease	  (ranging	  from	  10-­‐100	  fold)	  in	  ligand	  EC50	  for	  the	  mutant	  GC-­‐
C	   receptors	   was	   prominent.	   The	   in	   vitro	   assays	   suggested	   that	   the	   mutations	   occupying	  
different	  domains	  of	  GC-­‐C	  might	  have	  resulted	  in	  distinct	  structural	  consequences	  reflected	  
in	  the	  repertoire	  of	  phenotypes	  that	  were	  observed.	  	  
	  
The	  results	  presented	  in	  this	  thesis	  illustrate	  the	  molecular	  basis	  of	  the	  severe	  form	  
of	  congenital	  diarrhea	  associated	  with	   the	  GC-­‐C	  gain-­‐of-­‐function	  mutations.	  This	  study	  has	  
also	  elaborated	  our	  understanding	  of	  the	  regulation	  of	  GC-­‐C	  activity	  by	  its	  various	  domains.	  	  
	  
	  
	  
	  
